Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Peterlabs Holdings Bhd's
Operating Income
for the
three
months ended in Jun. 2025 was RM-1.7 Mil. Peterlabs Holdings Bhd's Interest Expense for the
three
months ended in Jun. 2025 was RM-0.2 Mil.
did not have earnings to cover the interest expense.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Peterlabs Holdings Bhd's Interest Coverage or its related term are showing as below:
XKLS:0171'
s Interest Coverage Range Over the Past 10 Years
Min: 2.5 Med: 11.13 Max: 16.15
Current: 2.5
XKLS:0171's Interest Coverage is ranked worse than 81.75% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs XKLS:0171: 2.50
Peterlabs Holdings Bhd (XKLS:0171) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Peterlabs Holdings Bhd Interest Coverage Related Terms
Peterlabs Holdings Bhd Interest Coverage Historical Data
* Premium members only.
The historical data trend for Peterlabs Holdings Bhd's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
XKLS:0171 vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peterlabs Holdings Bhd Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Peterlabs Holdings Bhd's Interest Coverage falls into.
Peterlabs Holdings Bhd Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Peterlabs Holdings Bhd did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of 0 (At Loss) mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Interest Coverage of 0 (At Loss) as of Jun. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Peterlabs Holdings Bhd and its competitors. Over the past decade, Peterlabs Holdings Bhd's Interest Coverage has ranged from 2.50 to 16.15. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #560 out of 685 companies in the Drug Manufacturers industry, placing it in the top 81.8%.
Is Peterlabs Holdings Bhd's Interest Coverage too high?
Peterlabs Holdings Bhd's current Interest Coverage is 0 (At Loss). Over the past 10 years, this metric has ranged from a low of 2.50 to a high of 16.15. Based on the distribution chart, Peterlabs Holdings Bhd ranks #560 out of 685 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #560 out of 685 companies for Interest Coverage. This places Peterlabs Holdings Bhd in the lower half of its industry. The industry median Interest Coverage is 12.78. Historically, Peterlabs Holdings Bhd's own Interest Coverage has ranged from 2.50 to 16.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 20% above its estimated fair value. The current Interest Coverage is 0 (At Loss). Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Interest Coverage is 0 (At Loss) as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued.
The current stock price of RM0.24 is trading 20% above its estimated GF Value™ of RM0.20.
GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:0171:
Interest Coverage: 0 (At Loss)
GF Value™: RM0.20 vs. price of RM0.24 (20% above fair value)
No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score
Get the complete analysis for XKLS:0171
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0171 has been successfully added to your 
